P974: INTERIM ANALYSIS OF THE LAUNCH STUDY-A MULTICENTER, OPEN-LABEL STUDY OF SELINEXOR, DEXAMETHASONE PLUS CHEMOTHERAPY DRUGS IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA

Chaoyang Sun,Baijun Fang,Guangxun Gao,Aili He,Fanfan Zhao,Junying Li,Chun Zhang,Weiming Li,Hui Cheng,Huili Cai,Bin Chen,Jing-Ming Guo,Yu Hu
DOI: https://doi.org/10.1097/01.hs9.0000970800.15485.de
2023-01-01
HemaSphere
Abstract:Exportin 1 (XPO1) participates the nuclear export of tumor suppressor proteins (TSPs), is associated with poor prognosis and drug resistance (PI or IMiD) in MM. Selinexor is a novel, oral
What problem does this paper attempt to address?